Skip to main content
Erschienen in: Journal of General Internal Medicine 8/2010

01.08.2010 | Original Research

Regular Primary Care Lowers Hospitalisation Risk and Mortality in Seniors with Chronic Respiratory Diseases

verfasst von: Kristjana Einarsdóttir, PhD, David B. Preen, PhD, Jon D. Emery, DPhil, FRACGP, Christopher Kelman, PhD, FAFPHM, C. D’Arcy J. Holman, PhD, FAFPHM

Erschienen in: Journal of General Internal Medicine | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

BACKGROUND

Exacerbations in chronic respiratory diseases (CRDs) are sensitive to seasonal variations in exposure to respiratory infectious agents and allergens and patient factors such as non-adherence. Hence, regular general practitioner (GP) contact is likely to be important in order to recognise symptom escalation early and adjust treatment.

OBJECTIVE

To examine the association of regularity of GP visits with all-cause mortality and first CRD hospitalisation overall and within groups of pharmacotherapy level in older CRD patients.

DESIGN

A retrospective cohort design using linked hospital, mortality, Medicare and pharmaceutical data for participant, exposure and outcome ascertainment. GP visit pattern was measured during the first 3 years of the observation period. Patients were then followed for a maximum of 11.5 years for ascertainment of hospitalisations and deaths.

PARTICIPANTS

We studied 108,455 patients aged ≥65 years with CRD in Western Australia (WA) during 1992–2006.

MAIN MEASURES

A GP visit regularity score (range 0–1) was calculated and divided into quintiles. A clinician consensus panel classified levels of pharmacotherapy. Cox proportional hazards models, controlling for multiple factors including GP visit frequency, were used to calculate hazard ratios and confidence intervals.

KEY RESULTS

Differences in survival curves and hospital avoidance pattern between the GP visit regularity quintiles were statistically significant (p = 0.0279 and p < 0.0001, respectively). The protective association between GP visit regularity and death appeared to be confined to the highest pharmacotherapy level group (P for interaction = 0.0001). Higher GP visit regularity protected against first CRD hospitalisation compared with the least regular quintile regardless of pharmacotherapy level (medium regular: HR = 0.84, 95% CI = 0.77–0.92; 2nd most regular: HR = 0.74, 95% CI = 0.67–0.82; most regular HR = 0.77, 95% CI = 0.68–0.86).

CONCLUSIONS

The findings indicate that regular and proactive ‘maintenance’ primary care, as distinct from ‘reactive’ care, is beneficial to older CRD patients by reducing their risks of hospitalisation and death.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Asthma in Australia 2008. Canberra: Australian centre for asthma monitoring and Australian Institute of Health and Welfare; 2008. Report No.: AIHW cat. no. ACM 14. Asthma in Australia 2008. Canberra: Australian centre for asthma monitoring and Australian Institute of Health and Welfare; 2008. Report No.: AIHW cat. no. ACM 14.
2.
Zurück zum Zitat Asthma Management Handbook 2006. Melbourne: National Asthma Council Australia; 2006. Asthma Management Handbook 2006. Melbourne: National Asthma Council Australia; 2006.
3.
Zurück zum Zitat Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. Australian Institute of Health and Ageing. Canberra; 2007. Report No.: AIHW cat. no. PHE 82. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. Australian Institute of Health and Ageing. Canberra; 2007. Report No.: AIHW cat. no. PHE 82.
4.
Zurück zum Zitat Frith PA, Cafarella PA, Duffy JM. Chronic obstructive pulmonary disease (COPD) is a major personal and public health burden in Australia. Aust N Z J Public Health. 2008;32:139–41.CrossRefPubMed Frith PA, Cafarella PA, Duffy JM. Chronic obstructive pulmonary disease (COPD) is a major personal and public health burden in Australia. Aust N Z J Public Health. 2008;32:139–41.CrossRefPubMed
5.
Zurück zum Zitat Glasgow N. Systems for the management of respiratory disease in primary care—an international series: Australia. Prim Care Respir J. 2008;17:19–25.CrossRefPubMed Glasgow N. Systems for the management of respiratory disease in primary care—an international series: Australia. Prim Care Respir J. 2008;17:19–25.CrossRefPubMed
6.
Zurück zum Zitat Tsai CL, Griswold SK, Clark S, Camargo CA Jr. Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen Intern Med. 2007;22:799–804.CrossRefPubMed Tsai CL, Griswold SK, Clark S, Camargo CA Jr. Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen Intern Med. 2007;22:799–804.CrossRefPubMed
7.
Zurück zum Zitat Cree M, Bell NR, Johnson D, Carriere KC. Increased continuity of care associated with decreased hospital care and emergency department visits for patients with asthma. Dis Manag. 2006;9:63–71.CrossRefPubMed Cree M, Bell NR, Johnson D, Carriere KC. Increased continuity of care associated with decreased hospital care and emergency department visits for patients with asthma. Dis Manag. 2006;9:63–71.CrossRefPubMed
8.
Zurück zum Zitat Shi L, Samuels ME, Pease M, Bailey WP, Corley EH. Patient characteristics associated with hospitalizations for ambulatory care sensitive conditions in South Carolina. South Med J. 1999;92:989–98.PubMed Shi L, Samuels ME, Pease M, Bailey WP, Corley EH. Patient characteristics associated with hospitalizations for ambulatory care sensitive conditions in South Carolina. South Med J. 1999;92:989–98.PubMed
9.
Zurück zum Zitat Rizza P, Bianco A, Pavia M, Angelillo IF. Preventable hospitalization and access to primary health care in an area of Southern Italy. BMC Health Serv Res. 2007;7:134.CrossRefPubMed Rizza P, Bianco A, Pavia M, Angelillo IF. Preventable hospitalization and access to primary health care in an area of Southern Italy. BMC Health Serv Res. 2007;7:134.CrossRefPubMed
10.
Zurück zum Zitat Parchman ML, Culler SD. Preventable hospitalizations in primary care shortage areas. An analysis of vulnerable Medicare beneficiaries. Arch Fam Med. 1999;8:487–91.CrossRefPubMed Parchman ML, Culler SD. Preventable hospitalizations in primary care shortage areas. An analysis of vulnerable Medicare beneficiaries. Arch Fam Med. 1999;8:487–91.CrossRefPubMed
11.
Zurück zum Zitat Bindman AB, Grumbach K, Osmond D, et al. Preventable hospitalizations and access to health care. JAMA. 1995;274:305–11.CrossRefPubMed Bindman AB, Grumbach K, Osmond D, et al. Preventable hospitalizations and access to health care. JAMA. 1995;274:305–11.CrossRefPubMed
12.
Zurück zum Zitat Basu J, Friedman B, Burstin H. Primary care, HMO enrollment, and hospitalization for ambulatory care sensitive conditions: a new approach. Med Care. 2002;40:1260–9.CrossRefPubMed Basu J, Friedman B, Burstin H. Primary care, HMO enrollment, and hospitalization for ambulatory care sensitive conditions: a new approach. Med Care. 2002;40:1260–9.CrossRefPubMed
13.
Zurück zum Zitat Sunyer J, Anto JM, McFarlane D, et al. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:851–6.PubMed Sunyer J, Anto JM, McFarlane D, et al. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:851–6.PubMed
14.
Zurück zum Zitat Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128:2640–6.CrossRefPubMed Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128:2640–6.CrossRefPubMed
15.
Zurück zum Zitat Dantzer C, Tessier JF, Nejjari C, Barberger-Gateau P, Dartigues JF. Mortality of elderly subjects with self-reported asthma in a French cohort, 1991–1996. Eur J Epidemiol. 2001;17:57–63.CrossRefPubMed Dantzer C, Tessier JF, Nejjari C, Barberger-Gateau P, Dartigues JF. Mortality of elderly subjects with self-reported asthma in a French cohort, 1991–1996. Eur J Epidemiol. 2001;17:57–63.CrossRefPubMed
16.
Zurück zum Zitat Bellia V, Pedone C, Catalano F, et al. Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest. 2007;132:1175–82.CrossRefPubMed Bellia V, Pedone C, Catalano F, et al. Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest. 2007;132:1175–82.CrossRefPubMed
17.
Zurück zum Zitat Restrepo RD. Use of inhaled anticholinergic agents in obstructive airway disease. Respir Care. 2007;52:833–51.PubMed Restrepo RD. Use of inhaled anticholinergic agents in obstructive airway disease. Respir Care. 2007;52:833–51.PubMed
18.
Zurück zum Zitat Phua GC, Macintyre NR. Inhaled corticosteroids in obstructive airway disease. Respir Care. 2007;52:852–8.PubMed Phua GC, Macintyre NR. Inhaled corticosteroids in obstructive airway disease. Respir Care. 2007;52:852–8.PubMed
19.
Zurück zum Zitat Miller-Larsson A, Selroos O. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists. Curr Pharm Des. 2006;12:3261–79.CrossRefPubMed Miller-Larsson A, Selroos O. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists. Curr Pharm Des. 2006;12:3261–79.CrossRefPubMed
20.
Zurück zum Zitat Yawn BP. Factors accounting for asthma variability: achieving optimal symptom control for individual patients. Prim Care Respir J. 2008;17:138–47.CrossRefPubMed Yawn BP. Factors accounting for asthma variability: achieving optimal symptom control for individual patients. Prim Care Respir J. 2008;17:138–47.CrossRefPubMed
21.
Zurück zum Zitat Walter MJ, Castro M, Kunselman SJ, et al. Predicting worsening asthma control following the common cold. Eur Respir J. 2008;32:1548–54.CrossRefPubMed Walter MJ, Castro M, Kunselman SJ, et al. Predicting worsening asthma control following the common cold. Eur Respir J. 2008;32:1548–54.CrossRefPubMed
22.
Zurück zum Zitat Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999;23:453–9.CrossRefPubMed Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999;23:453–9.CrossRefPubMed
23.
Zurück zum Zitat Harris MG, Harris RD. The Australian health system: continuity and change. J Health Hum Serv Adm. 1998;20:442–67.PubMed Harris MG, Harris RD. The Australian health system: continuity and change. J Health Hum Serv Adm. 1998;20:442–67.PubMed
24.
Zurück zum Zitat Medicare Benefits Schedule Book. Canberra: Department of Health and Ageing, Australian government; 2008. Medicare Benefits Schedule Book. Canberra: Department of Health and Ageing, Australian government; 2008.
25.
Zurück zum Zitat Liu H, Wong L. Data mining tools for biological sequences. J Bioinform Comput Biol. 2003;1:139–67.CrossRefPubMed Liu H, Wong L. Data mining tools for biological sequences. J Bioinform Comput Biol. 2003;1:139–67.CrossRefPubMed
26.
Zurück zum Zitat Tamim H, Monfared AA, LeLorier J. Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol Drug Saf. 2007;16:250–8.CrossRefPubMed Tamim H, Monfared AA, LeLorier J. Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol Drug Saf. 2007;16:250–8.CrossRefPubMed
27.
Zurück zum Zitat Strom BL. Pharmacoepidemiology. 4th ed. West Sussex: Wiley; 2005. Strom BL. Pharmacoepidemiology. 4th ed. West Sussex: Wiley; 2005.
28.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
29.
Zurück zum Zitat Patterns of asthma medication use in Australia. Canberra: Australian Centre for Asthma Monitoring and Australian Institute of health and welfare; 2007. Report No.: AIHW cat. no. ACM 11. Patterns of asthma medication use in Australia. Canberra: Australian Centre for Asthma Monitoring and Australian Institute of health and welfare; 2007. Report No.: AIHW cat. no. ACM 11.
30.
Zurück zum Zitat Cranston JM, Crockett AJ, Moss JR, Pegram RW, Stocks NP. Models of chronic disease management in primary care for patients with mild-to-moderate asthma or COPD: a narrative review. Med J Aust. 2008;188:S50–2.PubMed Cranston JM, Crockett AJ, Moss JR, Pegram RW, Stocks NP. Models of chronic disease management in primary care for patients with mild-to-moderate asthma or COPD: a narrative review. Med J Aust. 2008;188:S50–2.PubMed
31.
Zurück zum Zitat Sin DD, Tu JV. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest. 2001;119:720–5.CrossRefPubMed Sin DD, Tu JV. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest. 2001;119:720–5.CrossRefPubMed
32.
Zurück zum Zitat Schmier JK, Halpern MT, Jones ML. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence. Drugs Aging. 2005;22:717–29.CrossRefPubMed Schmier JK, Halpern MT, Jones ML. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence. Drugs Aging. 2005;22:717–29.CrossRefPubMed
33.
Zurück zum Zitat Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther. 2007;32:603–11.CrossRefPubMed Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther. 2007;32:603–11.CrossRefPubMed
34.
Zurück zum Zitat Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest. 1999;116:603–13.CrossRefPubMed Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest. 1999;116:603–13.CrossRefPubMed
35.
Zurück zum Zitat Vollmer WM, Peters D, Crane B, Kelleher C, Buist AS. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes. COPD. 2007;4:135–42.CrossRefPubMed Vollmer WM, Peters D, Crane B, Kelleher C, Buist AS. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes. COPD. 2007;4:135–42.CrossRefPubMed
36.
Zurück zum Zitat Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:580–4.PubMed Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:580–4.PubMed
37.
Zurück zum Zitat Sin DD, Tu JV. Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics. Eur Respir J. 2001;17:380–5.CrossRefPubMed Sin DD, Tu JV. Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics. Eur Respir J. 2001;17:380–5.CrossRefPubMed
38.
Zurück zum Zitat Balkrishnan R, Christensen DB. Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease. Clin Ther. 2000;22:452–69.CrossRefPubMed Balkrishnan R, Christensen DB. Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease. Clin Ther. 2000;22:452–69.CrossRefPubMed
39.
Zurück zum Zitat Radeos MS, Leak LV, Lugo BP, Hanrahan JP, Clark S, Camargo CA Jr. Risk factors for lack of asthma self-management knowledge among ED patients not on inhaled steroids. Am J Emerg Med. 2001;19:253–9.CrossRefPubMed Radeos MS, Leak LV, Lugo BP, Hanrahan JP, Clark S, Camargo CA Jr. Risk factors for lack of asthma self-management knowledge among ED patients not on inhaled steroids. Am J Emerg Med. 2001;19:253–9.CrossRefPubMed
40.
Zurück zum Zitat Goeman DP, Aroni RA, Sawyer SM, et al. Back for more: a qualitative study of emergency department reattendance for asthma. Med J Aust. 2004;180:113–7.PubMed Goeman DP, Aroni RA, Sawyer SM, et al. Back for more: a qualitative study of emergency department reattendance for asthma. Med J Aust. 2004;180:113–7.PubMed
41.
Zurück zum Zitat Fernandes AK, Mallmann F, Steinhorst AM, et al. Characteristics of acute asthma patients attended frequently compared with those attended only occasionally in an emergency department. J Asthma. 2003;40:683–90.CrossRefPubMed Fernandes AK, Mallmann F, Steinhorst AM, et al. Characteristics of acute asthma patients attended frequently compared with those attended only occasionally in an emergency department. J Asthma. 2003;40:683–90.CrossRefPubMed
42.
Zurück zum Zitat Adams RJ, Smith BJ, Ruffin RE. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax. 2000;55:566–73.CrossRefPubMed Adams RJ, Smith BJ, Ruffin RE. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax. 2000;55:566–73.CrossRefPubMed
Metadaten
Titel
Regular Primary Care Lowers Hospitalisation Risk and Mortality in Seniors with Chronic Respiratory Diseases
verfasst von
Kristjana Einarsdóttir, PhD
David B. Preen, PhD
Jon D. Emery, DPhil, FRACGP
Christopher Kelman, PhD, FAFPHM
C. D’Arcy J. Holman, PhD, FAFPHM
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 8/2010
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1361-6

Weitere Artikel der Ausgabe 8/2010

Journal of General Internal Medicine 8/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.